Gervacio, Theresa T.
HRN: 24-54-68 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/29/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
02/29/2024
02/08/2024
IV
600
Now Then Q8
Prophylaxis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes